Case Report
Daratumumab as first line therapy in primary effusion lymphoma: a case report
Annals of Lymphoma
2021;
5:
33
(30 December 2021)
Review Article
Minimal residual disease in follicular lymphoma
Annals of Lymphoma
2021;
5:
32
(30 December 2021)
Review Article
From pathobiology to targeted treatment in Epstein Barr virus related T cell and Natural Killer cell lymphoproliferative diseases
Annals of Lymphoma
2021;
5:
31
(30 December 2021)